Hein Park Capital Management LP In its 13F for Q4 2024 (holdings as of December 31, 2024, filed February 14, 2025), Hein Park Capital Management LP reported 3 stock positions worth $126.6 million . Its top holding was Diebold Nixdorf (DBD) at 69.1% of the portfolio, followed by Surgery Partners (SGRY, 19.1% ) and Bausch Health Cos (BHC, 11.8% ). Compared with Q3 2024, it opened 1 new position and reduced 2. The biggest buy was a new position in Surgery Partners (SGRY) and the biggest sale Diebold Nixdorf (DBD, shares −25% ).
Location New York, NY
CIK 0001826937
Portfolio Value $126.6M (Q4 2024) Holdings 3 stocks · $126.6M Holdings quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock % Of Portfolio ▼ Shares Held Total Value Change vs Q3 2024 DBD Diebold Nixdorf Inc. 69.14% 2,033,104 $87.5M Reduce -25.4% SGRY Surgery Partners Inc. 19.06% 1,139,227 $24.1M New BHC Bausch Health Cos Inc. 11.80% 1,853,379 $14.9M Reduce -0.0%
Other holdings (1): bonds, preferreds, convertibles and warrants · $3.6M (not counted above) Security Class Shares / Principal Value Change HTZWW Hertz Global Hldgs Inc. -CW51 *W EXP 06/30/205 1,683,087 $3.6M No change
Total filed on the 13F, all lines: $130.2M.
Portfolio Sells Q3 2024 → Q4 2024 Portfolio Sells quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q3 2024 % Of Portfolio Change To Portfolio ▲ DBD Diebold Nixdorf Inc. Reduce -25.4% 69.14% −19.81 BHC Bausch Health Cos Inc. Reduce -0.0% 11.80% +0.76
Portfolio Buys Q3 2024 → Q4 2024 Portfolio Buys quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q3 2024 % Of Portfolio Change To Portfolio ▼ SGRY Surgery Partners Inc. New 19.06% +19.06
All Filings Quarter Positions 13F Reported Value Top Holdings Q2 2026 2 $50.2M CZR, SGRY Q1 2026 1 $61.3M CZR Q4 2025 1 $54.3M CZR Q3 2025 2 $85.5M CZR, DBD Q2 2025 2 $136.1M DBD, CZR Q1 2025 3 $181.7M DBD, CZR, SGRY Q4 2024 3 $126.6M DBD, SGRY, BHC Q3 2024 2 $136.9M DBD, BHC Q2 2024 2 $123.7M DBD, BHC Q1 2024 2 $122.9M DBD, BHC